120 related articles for article (PubMed ID: 32956111)
1. Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT.
Ding J; Cheng X; Hou G; Jing H; Huo L
Clin Nucl Med; 2021 Jan; 46(1):71-73. PubMed ID: 32956111
[TBL] [Abstract][Full Text] [Related]
2. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
Pan Q; Zhang X; Luo Y; Ma Y; Li F
Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
[TBL] [Abstract][Full Text] [Related]
3. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
Luo Y; Wang L; Pan Q; Ma Y; Li F
Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
5. Colonic Castleman Disease on FDG PET/CT.
Li F; Xiao L; Cai H; Li L
Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
7. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
Fu Z; Liu M; Chen X; Yang X; Li Q
Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
[TBL] [Abstract][Full Text] [Related]
9. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
Wang P; Hou G; Li F; Cheng X
Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
[TBL] [Abstract][Full Text] [Related]
10. PET/CT imaging with 18F-FDG in Castleman disease.
Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
[No Abstract] [Full Text] [Related]
11. Unilateral Adrenal Cryptococcosis on FDG PET/CT.
Zhou J; Lv J; Pan Y; Xie J; Zhang Y
Clin Nucl Med; 2017 Jul; 42(7):565-566. PubMed ID: 28368884
[TBL] [Abstract][Full Text] [Related]
12. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE and 18F-FDG in Castleman Disease.
Verçosa AFA; Flamini MEDM; Loureiro LVM; Flamini RC
Clin Nucl Med; 2020 Nov; 45(11):868-870. PubMed ID: 32969902
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
Qiao Z; Zhang J; Jin X; Huo L; Zhu Z; Xing H; Li F
Clin Nucl Med; 2015 May; 40(5):397-400. PubMed ID: 25706799
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT Findings in TAFRO Syndrome.
Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
[TBL] [Abstract][Full Text] [Related]
16. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
Xiao L; Zhu HM; Li L
Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Nilica B; Waitz D; Stevanovic V; Uprimny C; Kendler D; Buxbaum S; Warwitz B; Gerardo L; Henninger B; Virgolini I; Rodrigues M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1585-92. PubMed ID: 26922350
[TBL] [Abstract][Full Text] [Related]
19. [Value of
Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
[TBL] [Abstract][Full Text] [Related]
20. Adrenal cryptococcosis in an immunosuppressed patient showing intensely increased metabolic activity on
Papadakis GZ; Holland SM; Quezado M; Patronas NJ
Endocrine; 2016 Dec; 54(3):834-836. PubMed ID: 27473097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
